| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.9514 | 27 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.5896 | 25 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.9041 | 36 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.9166 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.3483 | 15 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.236 | 46 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.9143 | 27 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.3786 | 34 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 49.4468 | 47 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.1154 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.8775 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.9629 | 32 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.6731 | 21 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.5657 | 20 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.9679 | 27 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.6675 | 35 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.457 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 39.9192 | 6 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.7105 | 21 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.6975 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.9523 | 22 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.0067 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.1969 | 38 |